Does TEMSIROLIMUS Cause Malignant neoplasm progression? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Malignant neoplasm progression have been filed in association with TEMSIROLIMUS (Temsirolimus). This represents 1.8% of all adverse event reports for TEMSIROLIMUS.
30
Reports of Malignant neoplasm progression with TEMSIROLIMUS
1.8%
of all TEMSIROLIMUS reports
10
Deaths
7
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TEMSIROLIMUS?
Of the 30 reports, 10 (33.3%) resulted in death, 7 (23.3%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEMSIROLIMUS. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does TEMSIROLIMUS Cause?
Disease progression (158)
Death (136)
Stomatitis (100)
Anaemia (89)
Neoplasm progression (84)
Vomiting (81)
Diarrhoea (79)
Febrile neutropenia (78)
Pneumonia (76)
Off label use (75)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TEMSIROLIMUS Alternatives Have Lower Malignant neoplasm progression Risk?
TEMSIROLIMUS vs TENAMFETAMINE
TEMSIROLIMUS vs TENAPANOR
TEMSIROLIMUS vs TENECTEPLASE
TEMSIROLIMUS vs TENELIGLIPTIN
TEMSIROLIMUS vs TENIPOSIDE